Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
10 Patents
#202 in Seattle, WA
#687 in Washington
#29,892 in US
#56,119 in the World
Impel Neuropharma, Inc.
Forward Citations = 31
12 inventors:
Seattle, WA, United States of America
Impel Neuropharma, Inc.
Calculating rank
EPO Patents = 4
Trademarks = 5
Forward Citations = 31
Loading Chart...
Loading Chart...
12 inventors (with patents filed for the assignee):
John D Hoekman (10 out of 21 patents)
Alan Brunelle (7 out of 12 patents)
Michael Hite (5 out of 14 patents)
4. Joel Relethford (5 out of 7 patents)
5. Christopher William Fuller (4 out of 9 patents)
6. Craig Frederick Kohring (3 out of 8 patents)
7. Kelsey H Satterly (2 out of 5 patents)
8. Rodney J Y Ho (2 out of 10 patents)
9. Inna Dashevsky (1 out of 4 patents)
10. Aditya R Das (1 out of 4 patents)
11. Scott Youmans (1 out of 11 patents)
12. Stephen B Shrewsbury (1 out of 8 patents)
10 patents:
Company Overview
Impel Neuropharma, Inc. is a biotechnology company based in Seattle, Washington, focused on developing innovative therapies for neurological conditions. The company specializes in drug delivery systems that enhance the efficacy of treatments for diseases such as migraine and other central nervous system disorders. By leveraging advanced technology, Impel aims to improve patient outcomes through targeted and efficient delivery mechanisms, addressing unmet medical needs in the field of neurology.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Impel Neuropharma, Inc.. Retrieved from https://idiyas.com/company/impel-neuropharma
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
4 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]